Geneva, March 20 -- International Clinical Trials Registry received information related to the study (CTRI/2026/02/104811) titled 'SPF of Foxtale FMSS1' on Feb. 25.
Study Type: PMS
Study Design:
Single Arm Study Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Open Label
Primary Sponsor: Foxtale Consumer Pvt Ltd.
Intervention:
Intervention1: Test Product: FMSS1: Quantity2 mg/sq.cm Route of administration: Topical Frequency: Once Duration: 24 hour
Control Intervention1: Reference Sunscreens: Quantity2 mg/sq.cm Route of administration: Topical Frequency: Once Duration: 24 hour
Recruitment Status: Not Recruiting
Phase: Post Marketing Surveillance
D...